ZyVersa Therapeutics, Inc.

Navigate ZyVersa Therapeutics, Inc.

Home
About
Inflammasomes
Renal Lipids
Pipeline
Careers
News Center
Contact

Announcement

Variant Pharmaceuticals Has a New Name - ZyVersa Therapeutics, Inc.

Home
News Center
Corporate Presentations

News Center

Corporate News Releases
Corporate Presentations
Media Resources
Corporate Media Contact

Corporate Presentations

ZyVersa Corporate Presentation Q4 2019
Uploaded: Oct 1, 2019
Type: Pdf

About ZyVersa

ZyVersa is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. Our focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases.

ZyVersa Therapeutics, Inc.

About
Inflammasomes
Renal Lipids
Pipeline
Careers
News Center
Contact

© 2019 ZyVersa Therapeutics, Inc. All Rights Reserved.
Website by Equisolve
Privacy Policy
Disclaimer
Trademarks
Sitemap